Pfizer layoffs put tax breaks in question

As Pfizer works to lay off some 600 of its workers in St. Louis, local officials are considering canceling the remainder of a $6.7 million property tax abatement, and other municipalities are ruing the day they gave tax breaks to the drugmaker. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.